Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: rituximab | Statement: [R-CHOP, containsMonoclonalAntibody, rituximab]

Target entity: rituximab
Context triple: [R-CHOP, containsMonoclonalAntibody, rituximab]

• A. Rituxan chosen
  Rituxan is a monoclonal antibody drug (rituximab) widely used to treat certain blood cancers and autoimmune diseases by targeting the CD20 protein on B cells.
• B. Ofatumumab
  Ofatumumab is a fully human monoclonal antibody used primarily in the treatment of certain B‑cell malignancies and relapsing forms of multiple sclerosis.
• C. ocrelizumab
  Ocrelizumab is a humanized monoclonal antibody used as a disease-modifying therapy for multiple sclerosis, particularly targeting CD20-positive B cells to reduce disease activity.
• D. isatuximab
  Isatuximab is a monoclonal antibody drug used primarily in the treatment of multiple myeloma by targeting and killing malignant plasma cells.
• E. Imbruvica
  Imbruvica is a targeted cancer therapy (a Bruton's tyrosine kinase inhibitor) used primarily to treat certain types of blood cancers such as mantle cell lymphoma and chronic lymphocytic leukemia.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target predicate: containsMonoclonalAntibody
Context triple: [R-CHOP, containsMonoclonalAntibody, rituximab]

• A. associatedWithAntibody
  Indicates a relationship where something is linked or connected to a specific antibody, such as being produced by it, targeted by it, or otherwise functionally related to it.
• B. antibodyType
  Indicates the specific class or subtype of an antibody involved in the described relationship or context.
• C. basedOnAntibody chosen
  Indicates that something is derived from, developed using, or fundamentally dependent on a specific antibody.
• D. hasMolecularTarget
  Indicates that one entity (such as a drug or compound) is directed toward, binds to, or specifically interacts with a particular molecular target (such as a protein, receptor, or gene).
• E. antigen
  Indicates that one entity functions as an antigen in relation to another, typically provoking or being recognized by an immune response.
• F. None of above.